KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables: 2020-2025

Historic Receivables for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Sep 2025 value amounting to $32.6 million.

  • Ginkgo Bioworks Holdings' Receivables rose 3.55% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.1 million, marking a year-over-year increase of 11.38%. This contributed to the annual value of $33.2 million for FY2024, which is 21.65% up from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Receivables of $32.6 million as of Q3 2025, which was down 1.28% from $33.1 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Receivables peaked at $178.1 million during Q2 2022, and registered a low of $24.2 million during Q1 2024.
  • Its 3-year average for Receivables is $41.1 million, with a median of $32.6 million in 2025.
  • Its Receivables has fluctuated over the past 5 years, first skyrocketed by 521.48% in 2021, then plummeted by 71.49% in 2024.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Receivables stood at $136.1 million in 2021, then slumped by 40.57% to $80.9 million in 2022, then tumbled by 66.31% to $27.3 million in 2023, then grew by 21.65% to $33.2 million in 2024, then increased by 3.55% to $32.6 million in 2025.
  • Its last three reported values are $32.6 million in Q3 2025, $33.1 million for Q2 2025, and $26.3 million during Q1 2025.